Defective fat cells drive metabolic disease in lipodystrophy
Many people may have a dim view of their fat tissue, yet scientists have come to recognize adipose…
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…
American women show varied preferences for in-clinic versus at-home cervical cancer screening
American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools.…
Smartwatch data may help detect opioid misuse risk
Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for…
Rapid zebrafish model mimics muscle aging and sarcopenia
As people age, muscles naturally lose mass and strength, a condition known as sarcopenia. The decline can make…
Single-dose HIV vaccine candidate induces neutralizing antibodies
Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in…
New 2026 guideline expands access to advanced acute ischemic stroke care
Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among…
Targeted uterine mRNA treatment boosts fertility outcomes in mice
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine – which designs nanotechnology-based platforms for…
Brain cell precursors show constant myelin-making drive
In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells – one…
Moffitt researchers develop a new way to predict how cancer cells evolve
Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing…
Study shows DHPS enzyme controls macrophage maturation across multiple organs
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…
Weill Cornell Medicine receives ARPA-H award to advance lymphatic disease diagnosis
Weill Cornell Medicine has received a $5.2 million, initial two-year award from the Advanced Research Projects Agency for…